Literature DB >> 27452418

Polymeric prodrug-functionalized polypropylene films for sustained release of salicylic acid.

Hector Magaña1, Kenia Palomino1, Jose M Cornejo-Bravo2, Luis Díaz-Gómez3, Angel Concheiro3, Edgar Zavala-Lagunes4, Carmen Alvarez-Lorenzo5, Emilio Bucio6.   

Abstract

Medical devices decorated with salicylic acid-based polymer chains (polymeric prodrug) that slowly release this anti-inflammatory and anti-biofilm drug at the implantation site were designed. A "grafting from" method was implemented to directly grow chains of a polymerizable derivative of salicylic acid (2-methacryloyloxy-benzoic acid, 2MBA) onto polypropylene (PP). PP was modified both at bulk and on the surface with poly(2MBA) by means of an oxidative pre-irradiation method ((60)Co source), in order to obtain a grafted polymer in which salicylic acid units were linked by means of labile ester bonds. The grafting percent depended on absorbed dose, reaction time, temperature and monomer concentration. The functionalized films were analyzed regarding structure (FTIR-ATR, SEM-EDX, fluorescence microscopy), temperature stability (TGA), interaction with aqueous medium (water contact angle and swelling), pH-responsive release and cytocompatibility (fibroblasts). In the obtained poly(2MBA)-grafted biomaterial, poly(2MBA) behaved as a polymeric prodrug that regulates salicylic acid release once in contact with aqueous medium, showing pH-dependent release rate.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Grafting; Polymer-drug conjugate; Polypropylene; Salicylic acid release; pH-dependent release; γ-irradiation

Mesh:

Substances:

Year:  2016        PMID: 27452418     DOI: 10.1016/j.ijpharm.2016.07.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.

Authors:  Can Huang; Na-Mei Li; Pei Gao; Sa Yang; Qian Ning; Wen Huang; Zhi-Ping Li; Peng-Ju Ye; Li Xiang; Dong-Xiu He; Xiang-Wen Tan; Cui-Yun Yu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.